Paper39383136
Hederagenin regulates the migration and invasion of hepatocellular carcinoma cells through FOXO signaling pathway.
Bao S and 2 others. PLoS One, 2024. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Hederagenin regulates the migration and invasion of hepatocellular carcinoma cells through FOXO signaling pathway. Papers, record 39383136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39383136
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Hederagenin regulates the migration and invasion of hepatocellular carcinoma cells through FOXO signaling pathway.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Hepatocellular | Major topic |
| Liver Neoplasms | Major topic |
| Cell Movement | Major topic |
| Signal Transduction | Major topic |
| Forkhead Box Protein O1 | Major topic |
| Apoptosis | Major topic |
| Oleanolic Acid | Major topic |
| Cell Proliferation | Major topic |
| Neoplasm Invasiveness | Major topic |
| Humans | |
| Cell Line, Tumor | |
| Forkhead Transcription Factors | |
| Gene Expression Regulation, Neoplastic | |
| Receptor, IGF Type 1 |
Source PubMed
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33118813 | ZINC20-A Free Ultralarge-Scale Chemical Database for Ligand Discovery. | J Chem Inf Model | 2020 | https://conductscience.org/library/papers/33118813 | PubMed |
| 2 | 28404958 | Elevated FOXO6 expression correlates with progression and prognosis in gastric cancer. | Oncotarget | 2017 | https://conductscience.org/library/papers/28404958 | PubMed |
| 3 | 25695151 | FoxO6 inhibits cell proliferation in lung carcinoma through up-regulation of USP7. | Mol Med Rep | 2015 | https://conductscience.org/library/papers/25695151 | PubMed |
| 4 | 29456786 | Hederagenin Induces Apoptosis in Cisplatin-Resistant Head and Neck Cancer Cells by Inhibiting the Nrf2-ARE Antioxidant Pathway. | Oxid Med Cell Longev | 2017 | https://conductscience.org/library/papers/29456786 | PubMed |
| 5 | 36348189 | Hederagenin Suppresses Inflammation and Cartilage Degradation to Ameliorate the Progression of Osteoarthritis: An In vivo and In vitro Study. | Inflammation | 2023 | https://conductscience.org/library/papers/36348189 | PubMed |
| 6 | 32848779 | Hederagenin Attenuates Cerebral Ischaemia/Reperfusion Injury by Regulating MLK3 Signalling. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/32848779 | PubMed |
| 7 | 35308212 | A Comparative Study of Systems Pharmacology and Gene Chip Technology for Predicting Targets of a Traditional Chinese Medicine Formula in Primary Liver Cancer Treatment. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/35308212 | PubMed |
| 8 | 10694567 | Matrix metalloproteinases: biologic activity and clinical implications. | J Clin Oncol | 2000 | https://conductscience.org/library/papers/10694567 | PubMed |
| 9 | 31300030 | Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications. | J Hematol Oncol | 2019 | https://conductscience.org/library/papers/31300030 | PubMed |
| 10 | 33950214 | PLIP 2021: expanding the scope of the protein-ligand interaction profiler to DNA and RNA. | Nucleic Acids Res | 2021 | https://conductscience.org/library/papers/33950214 | PubMed |
| 11 | 28965871 | FOXO1: Another avenue for treating digestive malignancy? | Semin Cancer Biol | 2018 | https://conductscience.org/library/papers/28965871 | PubMed |
| 12 | 35539158 | Current knowledge and development of hederagenin as a promising medicinal agent: a comprehensive review. | RSC Adv | 2018 | https://conductscience.org/library/papers/35539158 | PubMed |
| 13 | 26651948 | Meta- and Orthogonal Integration of Influenza "OMICs" Data Defines a Role for UBR4 in Virus Budding. | Cell Host Microbe | 2015 | https://conductscience.org/library/papers/26651948 | PubMed |
| 14 | 35531007 | Anti-inflammatory effects of hederagenin on diabetic cardiomyopathy via inhibiting NF-κB and Smads signaling pathways in a type-2 diabetic mice model. | RSC Adv | 2019 | https://conductscience.org/library/papers/35531007 | PubMed |
| 15 | 36911825 | Hederagenin suppresses glioma cell biological activities via Nur77 in vitro study. | Food Sci Nutr | 2023 | https://conductscience.org/library/papers/36911825 | PubMed |
| 16 | 32372224 | FOXO transcription factor family in cancer and metastasis. | Cancer Metastasis Rev | 2020 | https://conductscience.org/library/papers/32372224 | PubMed |
| 17 | 26481049 | Hederagenin, a major component of Clematis mandshurica Ruprecht root, attenuates inflammatory responses in RAW 264.7 cells and in mice. | Int Immunopharmacol | 2015 | https://conductscience.org/library/papers/26481049 | PubMed |
| 18 | 35907753 | Inflammation: the incubator of the tumor microenvironment. | Trends Cancer | 2022 | https://conductscience.org/library/papers/35907753 | PubMed |
| 19 | 35266443 | Suppression of NOD-like receptor protein 3 inflammasome activation and macrophage M1 polarization by hederagenin contributes to attenuation of sepsis-induced acute lung injury in rats. | Bioengineered | 2022 | https://conductscience.org/library/papers/35266443 | PubMed |
| 20 | 29309929 | FoxO transcription factors in cancer metabolism. | Semin Cancer Biol | 2018 | https://conductscience.org/library/papers/29309929 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42346657 | Gingerol Enhances Osteogenic/Odontogenic Differentiation of Dental Pulp Stem Cells Impaired by Oxidative Stress via the Wnt/β-Catenin Pathway. | J Funct Biomater | 2026 | https://conductscience.org/library/papers/42346657 | PubMed |
| 41526552 | FOXO: a key target in regulating aging and age-related diseases. | Biogerontology | 2026 | https://conductscience.org/library/papers/41526552 | PubMed |
| 41452426 | Therapeutic potential of natural triterpenoids in liver cancer. | Med Oncol | 2025 | https://conductscience.org/library/papers/41452426 | PubMed |
| 41002121 | Advantages and Possibility of Transcription Factors FOXOs in HCC. | Cell Biochem Funct | 2025 | https://conductscience.org/library/papers/41002121 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| FOXO1 | 2308 | PubTator's text mining | https://conductscience.org/library/genes/2308 | NCBI Gene |
| FOXO6 | 100132074 | PubTator's text mining | https://conductscience.org/library/genes/100132074 | NCBI Gene |
| IGF1R | 3480 | PubTator's text mining | https://conductscience.org/library/genes/3480 | NCBI Gene |
| MMP2 | 4313 | PubTator's text mining | https://conductscience.org/library/genes/4313 | NCBI Gene |
| MMP9 | 4318 | PubTator's text mining | https://conductscience.org/library/genes/4318 | NCBI Gene |
| VEGFA | 7422 | PubTator's text mining | https://conductscience.org/library/genes/7422 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39383136
GET https://conductscience.org/api/papers/v1/39383136/references?page=2